High levels of antibiotic-resistant bacteria in the gut are linked to poorer outcomes in people with cirrhosis, according to new evidence published by VCU School of Medicine researchers, which could provide a new tool for determining prognosis and a potential new target for therapy.
The paper’s other authors were Chathur Acharya, Andrew Fagan, Edith Gavis, Sara McGeorge, Somaya Albaisi, Michael Fuchs and Richard K Sterling from VCU and the Central Virginia Veterans Healthcare System; Amirhossein Shamsaddini, Patrick M Gillevet and Masoumeh Sikaroodi from the Microbiome Analysis Center at George Mason University; and Alexander Khoruts from the University of Minnesota.
